semaglutide glp-1 for weight loss How Works to Help You Lose FDA Approves Oral Semaglutide: First

Description

Wadden and colleagues assessed changes in depressive symptoms using the Patient Health Questionnaire-9 (PHQ-9) and suicidal ideation or behaviors using the Columbia Suicide Severity Rating Scale in participants with overweight or obesity using semaglutide 2.4 mg or placebo

For each food keyword, we recorded total mention volume, average sentiment score (calculated across a sample of posts mentioning each food), and co-occurrence with a curated list of "favorite" phrases (e.g., "craving," "obsessed with," "my go-to") and "aversion" phrases (e.g., "can't eat," "makes me nauseous," "never again")

Jensen DM, Skovsted GF, Bonde MFB, Bentzon JF, Rolin B, Franck G, et al

The events at ARDD2025 have sparked urgent discussions among R&D leaders, all grappling with the same fundamental questions: What is the best way to discover and develop longevity therapeutics that will follow the GLP-1 story